Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Withdrawn × Myeloid × Clear all

Phase

Phase 2 29 Phase 1/2 19 Phase 1 19 Phase NA 5 Phase 3 3 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Completed 22 Unknown 8 Terminated 4 Recruiting 2 Active not recruiting 2 Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 12 Breast 11 Lymphoid 5 Tumor-Agnostic 4 Other hematologic neoplasm 3 Genitourinary 3 Classical hematology 3 CNS 3 Thoracic 2 Plasma cell 2 Head & Neck 2 Other 1 NET 1 Myeloid 1 Gynecologic 1 Endocrine 1 Dermatologic 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01605981 2017-04-20

MACS1881

Novartis

Phase 4 Withdrawn

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡